Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time Osteosarcoma (OS) is the most prevalent ...

Biosciences, announced that its collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an ...

OST-HER2 is an immunotherapy for osteosarcoma using a HER2 bioengineered form of the bacteria Listeria monocytogenes to trigger a strong immune response against cancer cells expressing HER2.

In this study we evaluated the immunohistochemical expression of ferritinophagy-related proteins, namely Ferritin Heavy chain (FTH1) and NCOA4, and proliferating cell nuclear antigen (PCNA) in canine ...

ECI®, the first autologous prescription product to receive USDA-CVB approval, is indicated for the treatment of canine osteosarcoma, a deadly form of bone cancer. Large and giant breed dogs ...

1 Department of Orthopedics, Central Hospital Affiliated to Shandong First Medical University, Jinan, China 2 Laboratory Medicine, Central Hospital Affiliated to Shandong First Medical University, ...

Key data will be presented from the Company’s Phase 2b clinical trial of OST-HER2 in the prevention of recurrent, fully resected, lung metastatic osteosarcoma. This data will be compared with a ...

Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, Shandong Province ...

Department of Biomedical Engineering, College of Automation Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing, Jiangsu 211106, P. R. China These authors contributed equally to ...